Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1–Positive Endometrial Cancer: Results From the KEYNOTE-028 Study

标题
Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1–Positive Endometrial Cancer: Results From the KEYNOTE-028 Study
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 35, Issue 22, Pages 2535-2541
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2017-05-11
DOI
10.1200/jco.2017.72.5952

向作者/读者发起求助以获取更多资源

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started